Evidence map›Paper›PMID 36596214›Full record

ArticleJournal of medical Internet research2023

User-Chatbot Conversations During the COVID-19 Pandemic: Study Based on Topic Modeling and Sentiment Analysis.

Hyojin Chin, Gabriel Lima, Mingi Shin, Assem Zhunis, Chiyoung Cha, Junghoi Choi, Meeyoung Cha

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. The performance of artificial intelligence chatbot large language models to address skeletal biology and bone health queries.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Impact of ChatGPT on medical chatbots as a disruptive technology.Frontiers in artificial intelligence · 2023
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hyojin ChinData Science Group, Institute for Basic Science, Daejeon, Republic of Korea.ORCID 0000-0003-4773-9518
Gabriel LimaData Science Group, Institute for Basic Science, Daejeon, Republic of Korea.ORCID 0000-0002-2361-350X
Mingi ShinSchool of Computing, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.ORCID 0000-0002-1871-7208
Assem ZhunisSchool of Computing, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.ORCID 0000-0003-0640-2425
Chiyoung ChaCollege of Nursing, Ewha Womans University, Seoul, Republic of Korea.ORCID 0000-0003-0115-1348
Junghoi ChoiSimSimi Inc, Seoul, Republic of Korea.ORCID 0000-0002-8540-5191
Meeyoung ChaData Science Group, Institute for Basic Science, Daejeon, Republic of Korea.ORCID 0000-0003-4085-9648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChatbots have become a promising tool to support public health initiatives. Despite their potential, little research has examined how individuals interacted with chatbots during the COVID-19 pandemic. Understanding user-chatbot interactions is crucial for developing services that can respond to people's needs during a global health emergency.

objectiveThis study examined the COVID-19 pandemic-related topics online users discussed with a commercially available social chatbot and compared the sentiment expressed by users from 5 culturally different countries.

methodsWe analyzed 19,782 conversation utterances related to COVID-19 covering 5 countries (the United States, the United Kingdom, Canada, Malaysia, and the Philippines) between 2020 and 2021, from SimSimi, one of the world's largest open-domain social chatbots. We identified chat topics using natural language processing methods and analyzed their emotional sentiments. Additionally, we compared the topic and sentiment variations in the COVID-19-related chats across countries.

resultsOur analysis identified 18 emerging topics, which could be categorized into the following 5 overarching themes: "Questions on COVID-19 asked to the chatbot" (30.6%), "Preventive behaviors" (25.3%), "Outbreak of COVID-19" (16.4%), "Physical and psychological impact of COVID-19" (16.0%), and "People and life in the pandemic" (11.7%). Our data indicated that people considered chatbots as a source of information about the pandemic, for example, by asking health-related questions. Users turned to SimSimi for conversation and emotional messages when offline social interactions became limited during the lockdown period. Users were more likely to express negative sentiments when conversing about topics related to masks, lockdowns, case counts, and their worries about the pandemic. In contrast, small talk with the chatbot was largely accompanied by positive sentiment. We also found cultural differences, with negative words being used more often by users in the United States than by those in Asia when talking about COVID-19.

conclusionsBased on the analysis of user-chatbot interactions on a live platform, this work provides insights into people's informational and emotional needs during a global health crisis. Users sought health-related information and shared emotional messages with the chatbot, indicating the potential use of chatbots to provide accurate health information and emotional support. Future research can look into different support strategies that align with the direction of public health policy.

Indexed as

COVID-19Social MediaCommunicable Disease ControlHumansPandemicsSARS-CoV-2Sentiment AnalysisUnited Stateschatbotconversational agentCOVID-19discourseglobal healthhealth informationinfodemiologyinfoveillancepublic healthpublic perceptionsentiment analysistopic modeling

Identifiers

PMID36596214
PMCPMC9885754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.